JNJ - Johnson & Johnson

Day 1m 10m 60m PreMarket Market AfterHours Gap
203.79 1.1 (0.54%) -0.23 (-0.11%) -0.44 (-0.21%) -0.86 (-0.42%) 0.41 (0.2%) 0.93 (0.46%) 0.5 (0.25%) 0.74 (0.36%)

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
2.3
Diluted EPS:
2.29
Basic P/E:
89.0826
Diluted P/E:
89.4716
RSI(14) 1m:
34.08
VWAP:
205.02
RVol:

Events

Period Kind Movement Occurred At

Related News